interleukin 13 ; Mus musculus






747 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 7492780 The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. Blood 1995 Dec 1 1
2 7688562 IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993 Jun 1
3 7744881 Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem 1995 May 19 2
4 7903102 Modulation of murine macrophage function by IL-13. J Immunol 1993 Dec 15 2
5 7909326 Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994 May 1 1
6 7911424 Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994 Jun 1
7 8543830 IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 1996 Jan 15 5
8 8912886 Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen. Cell Immunol 1996 Nov 1 1
9 8977218 Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997 Jan 1 3
10 9058827 IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol 1997 Mar 15 1
11 9129994 Suppression of in vivo IgE and tissue IL-4 mRNA induction by SDZ 280.636, a synthetic muramyl dipeptide derivative. Immunopharmacology 1997 Apr 1
12 9209514 Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur J Immunol 1997 Jun 1
13 9305732 Effect of IL-4 and IL-13 on IFN-gamma-induced production of nitric oxide in mouse macrophages infected with herpes simplex virus type 2. FEBS Lett 1997 Sep 1 2
14 9328138 Regulation of cytokine gene expression by adjuvants in vivo. Clin Exp Immunol 1997 Sep 5
15 9379051 Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol 1997 Nov 1 4
16 9486409 Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin Exp Immunol 1998 Feb 1
17 9748607 IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages. Biochim Biophys Acta 1998 Aug 28 6
18 9886369 IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 1999 Jan 1 2
19 10469236 Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice. Immunology 1999 Sep 1
20 10521702 IL-13 induces serine phosphorylation of cPLA2 in mouse peritoneal macrophages leading to arachidonic acid and PGE2 production and blocks the zymosan-induced serine phosphorylation of cPLA2 and eicosanoid production. Biochim Biophys Acta 1999 Sep 22 12
21 10569763 Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody. Infect Immun 1999 Dec 1
22 10861042 Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 2000 Jul 1 2
23 10882414 Failure of rIL-12 administration to inhibit established IgE responses in vivo is associated with enhanced IL-4 synthesis by non-B/non-T cells. Int Immunol 2000 Jul 1
24 10934105 Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am J Respir Crit Care Med 2000 Aug 2
25 10995789 IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000 Sep 1
26 11036873 Interleukin (IL)-4 and IL-13 inhibit the differentiation of murine osteoblastic MC3T3-E1 cells. Endocr J 2000 Jun 4
27 11067915 Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol 2000 Nov 15 1
28 11080527 Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol 2000 Nov 17 1
29 11090103 Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br J Pharmacol 2000 Dec 1
30 11160269 Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 2001 Feb 15 1
31 11170055 Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. J Med Virol 2001 Feb 2
32 11254693 IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol 2001 Apr 1 1
33 11331286 Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 2001 Jul 6 1
34 11466394 Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyperresponsiveness. J Immunol 2001 Aug 1 1
35 11489954 Interleukin (IL)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J Exp Med 2001 Aug 6 1
36 11591766 The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol 2001 Oct 15 1
37 11606024 Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. Int Immunopharmacol 2001 Oct 7
38 11734470 Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am J Respir Crit Care Med 2001 Nov 15 1
39 11745342 IL-13 gene-deficient mice are susceptible to cutaneous L. mexicana infection. Eur J Immunol 2001 Nov 2
40 11804843 Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2002 Feb 1
41 11826401 Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 2002 Feb 1
42 11884467 IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2002 Mar 15 1
43 11906244 Cytokine profiling for chemical sensitizers: application of the ribonuclease protection assay and effect of dose. Toxicol Appl Pharmacol 2002 Mar 15 2
44 11956061 Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2002 Apr 15 1
45 12003965 A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages. J Antimicrob Chemother 2002 May 3
46 12034862 Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice. Protein Eng 2002 May 1
47 12060560 Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 2002 Jul 1
48 12065288 Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2002 Jul 1
49 12161283 Expression of cytokine mRNAs in mice cutaneously exposed to formaldehyde. Immunol Lett 2002 Oct 21 1
50 12370375 Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 2002 Oct 15 4